Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess: the incidence of abnormal partial thromboplastin time in
patients receiving unfractionated heparin (UFH) 5000 U 2 times a day versus 3 times a day 72
hours after administration of the first dose of heparin.
Hypothesis: The basic hypothesis of this study is that patients receiving UFH 5000 U
subcutaneously 3 times a day will have a higher proportion of elevated partial thromboplastin
time than patients receiving UFH 5000 U subcutaneously twice a day.